111
Views
1
CrossRef citations to date
0
Altmetric
CASE REPORT

Successful Treatment of Severe Subcorneal Pustular Dermatosis with Adalimumab

, , , , , , & show all
Pages 2567-2570 | Received 28 Sep 2022, Accepted 10 Nov 2022, Published online: 28 Nov 2022

References

  • Watts PJ, Khachemoune A. Subcorneal pustular dermatosis: a review of 30 years of progress. Am J Clin Dermatol. 2016;17:653–671. doi:10.1007/s40257-016-0202-8
  • Romagnuolo M, Muratori S, Cattaneo A, et al. Successful treatment of refractory Sneddon-Wilkinson disease (subcorneal pustular dermatosis) with infliximab. Dermatol Ther. 2022;35:e15552. doi:10.1111/dth.15552
  • Guerin CJ, Beylot-Barry M, Frouin E, et al. Treatment of subcorneal pustular dermatosis (Sneddon-Wilkinson disease) with anti-tumor necrosis factor alpha. Cureus. 2021;13:e17147. doi:10.7759/cureus.17147
  • Caraballo L, Mahapatra S, Dimov V, et al. The striking appearance of a rare skin condition: “half-half” blisters (subcorneal pustular dermatosis). J Allergy Clin Immunol Pract. 2020;8:732–733. doi:10.1016/j.jaip.2019.09.018
  • Ranieri P, Bianchetti A, Trabucchi M. Sneddon-Wilkinson disease: a case report of a rare disease in a nonagenarian. J Am Geriatr Soc. 2009;57:1322–1323. doi:10.1111/j.1532-5415.2009.02337.x
  • Kretschmer L, Maul JT, Hofer T, et al. Interruption of Sneddon-Wilkinson subcorneal pustulation with infliximab. Case Rep Dermatol. 2017;9:140–144. doi:10.1159/000468917
  • Borgia F, Campitiello A, Di Bartolomeo L, et al. Subcorneal pustular dermatosis successfully treated with low-dose doxycycline. Int J Dermatol. 2021;60:e375–6. doi:10.1111/ijd.15530
  • Zachariae CO, Rossen K, Weismann K. An unusual severe case of subcorneal pustular dermatosis treated with cyclosporine and prednisolone. Acta Derm Venereol. 2000;80:386–387.
  • Canpolat F, Akpinar H, Cemil BC, et al. A case of subcorneal pustular dermatosis in association with monoclonal IgA gammopathy successfully treated with Acitretin. J Dermatolog Treat. 2010;21:114–116. doi:10.3109/09546630902882071
  • Voigtlander C, Luftl M, Schuler G, et al. Infliximab (anti-tumor necrosis factor alpha antibody): a novel, highly effective treatment of recalcitrant subcorneal pustular dermatosis (Sneddon-Wilkinson disease). Arch Dermatol. 2001;137:1571–1574. doi:10.1001/archderm.137.12.1571
  • de Encarnacao RDF, Dias CJ, Macedo FA, et al. Subcorneal pustular dermatosis treated successfully with Adalimumab. Eur J Dermatol. 2010;20:512–514. doi:10.1684/ejd.2010.0957
  • Grob JJ, Mege JL, Capo C, et al. Role of tumor necrosis factor-alpha in Sneddon-Wilkinson subcorneal pustular dermatosis. A model of neutrophil priming in vivo. J Am Acad Dermatol. 1991;25:944–947. doi:10.1016/0190-9622(91)70290-I
  • Garcia DP, Agudo-Mena JL, Gomez-Sanchez ME, et al. Recalcitrant pyoderma gangrenosum and subcorneal pustular dermatosis successfully treated with Adalimumab. Actas Dermosifiliogr. 2020;111:887–889. doi:10.1016/j.ad.2019.02.028
  • Versini M, Mantoux F, Angeli K, et al. [Sneddon-Wilkinson disease: efficacy of intermittent Adalimumab therapy after lost response to infliximab and etanercept]. Ann Dermatol Venereol. 2013;140:797–800. French. doi:10.1016/j.annder.2013.07.012
  • Sauder MB, Glassman SJ. Palmoplantar subcorneal pustular dermatosis following Adalimumab therapy for rheumatoid arthritis. Int J Dermatol. 2013;52:624–628. doi:10.1111/j.1365-4632.2012.05707.x